Congratulations on maintaining your complete cytogenetic response for many years. Your doctor obviously thought you were a good candidate for halving the dose as the trial that Nigel mentioned he was on is currently ongoing - but closed to new recruits.
The trial is called DESTINY which stands for DE-escalation and Stopping Treatment Imatinib Nilotinib and sprYcel. Several members of this forum have taken part and some are still enrolled on it. See the DESTINY discussion thread pinned to the top of this page for their experiences so far.
Data from the first 12 months of the trial has confirmed that it is very safe to halve the dose in patients who have had a stable major or deeper molecular response over at least 2 years and in the majority on the trial without loss of response. A small number did show signs that their BCR-ABL levels were moving in the wrong direction and were immediately put back on the full dose. None of those patients have relapsed and all have regained their previous responses.
Given that you have maintained such a deep molecular response for so long, I am sure you have nothing to worry about.
Sandy